PRESS & MEDIA

Learn about our latest press and news headlines!

Nov, 29, 2024

Exploring Global Market Access for Rare and Complex Conditions Part One: Overcoming challenges and seizing opportunities in global market access for rare and complex conditions

READ FULL STORY

Nov, 29, 2024

Exploring Global Market Access for Rare and Complex Conditions Part Two: Navigating the complexities of global market access for rare and complex conditions

READ FULL STORY

Nov, 25, 2024

Eylea Biosimilar Pavblu Enters Crowded Market With Some Uncertainty

READ FULL STORY

Nov, 25, 2024

Even at 10% Discount, Eylea Biosimilar Pavblu Offers Lower-Cost Option

READ FULL STORY

Nov, 21, 2024

AscellaHealth Ranked Number 154 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

READ FULL STORY

Oct, 22, 2024

AscellaHealth Releases Q3 2024 Specialty & Rare Pipeline Digest™: FDA-Approved Biosimilars Outpaces Cell and Gene Therapy Amid Complex Regulatory Challenges

READ FULL STORY

Oct, 17, 2024

AscellaHealth Announces its Strategic Acquisition of CHAPPER healthcare: Expands Global Specialty Pharmaceutical Wholesale and Product Distribution Services

READ FULL STORY

Oct, 16, 2024

Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®

READ FULL STORY

For more information about AscellaHealth

Awards and Accolades

AscellaHealth is proud to be recognized as a leading global specialty pharmacy and healthcare services organization. We have won multiple awards both within and outside of the healthcare industry.

Read our Privacy Policy to learn more. We use cookies to help us better understand how our customers interact with our website. Read our Privacy Policy to learn more.